COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,588 Articles (22,415 medRxiv, 8,173 bioRxiv)

Most recent first Previous |  Page 1714: Articles 17131-17140  | Next

Occupational exposures and mitigation strategies among homeless shelter workers at risk of COVID-19
Rao, C., Robinson, T., Huster, K., Laws, R., Keating, R., Tobolowsky, F., McMichael, T., Gonzales, E., Mosites, E.
10.1101/2021.02.22.21251646 — Posted: 2021-02-23
Clinical profile and factors associated with COVID-19 in Cameroon: a prospective cohort study
Fouda Mbarga, N., Epee, E., Mbarga, M., Ouamba, J. P., Nanda, H., Kengni, A., Guekeme, J., Eyong, J., Tossoukpe, S., Noumedem Sosso, S., Ngono Ngono, E., Bonyomo, L., Tchatchoua, P., Vogue, N., Metomb, S., Ale, F., Ousman, M., Job, D., Moussi, C., Tamakloe, M., Haberer, J. E., Ndeso Atanga, S., Halle Ekane, G., Boum, Y.
10.1101/2021.02.19.21252071 — Posted: 2021-02-23
Long-term air pollution and other risk factors associated with COVID-19 at the census-tract-level in Colorado
Berg, K., Romer Present, P., Richardson, K.
10.1101/2021.02.19.21252019 — Posted: 2021-02-23
Follow-up study in the ski-resort Ischgl: Antibody and T cell responses to SARS-CoV-2 persisted for up to 8 months after infection and transmission of virus was low even during the second infection wave in Austria
Borena, W., Banki, Z., Bates, K., Winner, H., Riepler, L., Roessler, A., Pipperger, L., Theurl, I., Falkensammer, B., Ulmer, H., Walser, A., Pichler, D., Baumgartner, M., Schoenherr, S., Forer, L., Knabl, L., Wuerzner, R., von Laer, D., Paetzold, J., Kimpel, J.
10.1101/2021.02.19.21252089 — Posted: 2021-02-23
Impact of the COVID-19 pandemic on mental health among Greek adults: a cross-sectional survey.
Dragotis, E., Atsopardi, K., Barbouni, A., Farsalinos, K., Poulas, K.
10.1101/2021.02.20.21252129 — Posted: 2021-02-23
Efferocytosis of SARS-CoV-2-infected dying cells impairs macrophage anti-inflammatory programming and continual clearance of apoptotic cells
dos-Santos, D., Salina, A. C. G., Rodrigues, T. S., Rocha, M. F., Freitas-Filho, E. G., Alzamora-Terrel, D. L., de Lima, M. H. F., Nascimento, D. B. C., Castro, I., Silva, C. M., Toller-Kawahisa, J. E., Becerra, A., Oliveira, S., Caetite, D. B., Almeida, L., Ishimoto, A. Y., Lima, T. M., Martins, R. B., Veras, F., do Amaral, N. B., Giannini, M. C., Bonjorno, L. P., Lopes, M. I. F., Benatti, M. N., Batah, S. S., Santana, R. C., Vilar, F. C., Martins, M. A., Assad, R. L., de Almeida, S. C. L., de Oliveira, F. R., Arruda Neto, E., Cunha, T. M., Alves-Filho, J. C., Cunha, F. Q., Fabro, A. T., Nakaya, H. I., Zamboni, D. S., Louzada-Junior, P., Oliveira, R. D. R., Cunha, L. D.
10.1101/2021.02.18.21251504 — Posted: 2021-02-23 Discussion: Onsite
The Association of Opioid Use Disorder and COVID-19 in Shahroud, Iran
Jamali, Z., Emamian, M. H., Hashemi, H., Fotouhi, A.
10.1101/2021.02.19.21252093 — Posted: 2021-02-23
Role of Heterogeneous Transmission in the Decline of COVID-19 Cases During Winter of 2020/2021 in Massachusetts
Choi, Y.-W., Castro, M. C., Eltahir, E. A. B.
10.1101/2021.02.18.21251955 — Posted: 2021-02-23
In search for the SARS-CoV-2 protection correlate: A head-to-head comparison of two quantitative S1 assays in a group of pre-characterized oligo-/asymptomatic patients
Rubio-Acero, R., Castelletti, N., Fingerle, V., Olbich, L., Bakuli, A., Woelfel, R., Girl, P., Mueller, K., Jochum, S., Strobl, M., Hoelscher, M., Wieser, A., KoCo19 study team
10.1101/2021.02.19.21252080 — Posted: 2021-02-23
Efficacy and safety of Ivermectin and Hydroxychloroquine in patients with severe COVID-19. A randomized controlled trial
Beltran-Gonzalez, J. L., Gonzalez-Gamez, M., Mendoza-Enciso, E.-A., Esparza-Maldonado, R. J., Hernanez-Palacios, D., Duenas-Campos, S., Ovalle-Robles, I., Macias-Guzman, M. J., Garcia Diaz, A. L., Gutierrez Pena, C. M., Martinez-Medina, L., Monroy Colin, V. M., Arreola Guerra, J. M. A.
10.1101/2021.02.18.21252037 — Posted: 2021-02-23 Discussion: Onsite | Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).